BamSEC and AlphaSense Join Forces
Learn More

TuHURA Biosciences Inc.

NASDAQ: HURA    
Share price (1/8/25): $4.17    
Market cap (1/8/25): $176 million
Search in Documents
Key Exhibits
External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.1
from 8-K 95 pages Agreement and Plan of Merger Among TuHURA Biosciences, Inc., HURA Merger Sub I, Inc. HURA Merger Sub II, LLC Kineta, Inc. and Craig Philips, Solely in His Capacity as Stockholders Representative Dated as of December 11, 2024
12/34/56
EX-2.3
from 8-K 4 pages Waiver Agreement
12/34/56
EX-2.1
from 8-K 4 pages Waiver Agreement
12/34/56
EX-2.1
from 425 4 pages Waiver Agreement
12/34/56
EX-2.1
from 425 104 pages Agreement and Plan of Merger by and Among Kintara Therapeutics, Inc., Kayak Mergeco, Inc. and Tuhura Biosciences, Inc. Dated as of April 2, 2024
12/34/56
EX-2.1
from 8-K 104 pages Agreement and Plan of Merger by and Among Kintara Therapeutics, Inc., Kayak Mergeco, Inc. and Tuhura Biosciences, Inc. Dated as of April 2, 2024
12/34/56
EX-2.1
from 425 82 pages Agreement and Plan of Merger and Reorganization Among: Delmar Pharmaceuticals, Inc., a Nevada Corporation; Adgero Acquisition Corp., a Delaware Corporation; and Adgero Biopharmaceuticals Holdings, Inc. a Delaware Corporation Dated as of June 9, 2020
12/34/56
EX-2.1
from 8-K 82 pages Agreement and Plan of Merger and Reorganization Among: Delmar Pharmaceuticals, Inc., a Nevada Corporation; Adgero Acquisition Corp., a Delaware Corporation; and Adgero Biopharmaceuticals Holdings, Inc. a Delaware Corporation Dated as of June 9, 2020
12/34/56
EX-2.1
from 8-K 58 pages Exchange Agreement Among Delmar Pharmaceuticals, Inc. and 0959456 B.C. Ltd. and 0959454 B.C. Ltd. and Del Mar Pharmaceuticals (Bc) Ltd. and Securityholders of Del Mar Pharmaceuticals (Bc) Ltd. January 25, 2013 I
12/34/56